Reduced infusion time with VYXEOS

Dosing and administration schedules for VYXEOS and 7+3a in the Phase 3 trial1,2

Induction

VYXEOS offers reduced infusion time compared to 7+3

Second induction (if needed)

VYXEOS offers reduced infusion time compared to 7+3

Consolidation (1-2 cycles)

VYXEOS offers reduced infusion time compared to 7+3
51% of patients received VYXEOS in an outpatient setting during consolidation in the Phase 3 trial3
  1. Cytarabine and daunorubicin.